Augmentation Review Stays Open as Clinics Report Steady Demand

The line for enhancement has not shortened, but the questions around it have grown louder. With augmented humans now above five percent of the population, the ongoing and still-contested safety review of neural-interface implants continues to divide clinicians and regulators, even as somatic-augmentation clinics report steady summer demand, according to practitioners across three cities. The review, which examines interface lines including those from Somaform Augmetics, remains open — neither cleared nor concluded — and Somaform founder Julian Morrow, an augmentation-rights advocate, has urged patience without a verdict. At a clinic in Jakarta, implant counselor Rizal Hakim said patients ask him the same thing daily: "Is it safe? And I have to tell them the honest answer is that people I respect are still arguing." Demand for lower-risk somatic augmentations remains brisk; the neural-interface question, counselors say, is where prudent patients now pause.